Press release
Acromegaly Pipeline and Therapeutic Assessment, Drug Development by Companies Reviewed for H1 2017
Market Research HUB
Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1068020
The report starts by presenting the acromegaly overview and its therapeutic development under the pipeline overview. Acromegaly is a serious systemic condition caused in over 98% of cases by an adenoma (i.e., benign tumor) of the pituitary gland that secretes excessive growth hormone (GH). It is a hormonal disorder that most commonly occurs in middle-aged men and women. The prevalence of acromegaly is approximately 4,676 cases per million population, and the incidence is 116.9 new cases per million per year. Symptoms include soft tissue thickening of the palms of the hands and soles of the feet, enlargement of hands, feet and head, Arthritis, Oily skin and excessive sweating, Fatigue, Hypertension, Headache etc. Treatment includes surgery, dopamine agonists and growth hormone antagonists. The most common treatment is to remove the adenoma by surgical treatment.
As per the key findings, the clinical diagnosis is confirmed biochemically by an increased serum GH concentration following an oral glucose tolerance test (OGTT) and by detection of increased levels of insulin-like growth factor-I (IGF-I). Moving further, this pipeline guide features drug profiles for the pipeline products which include, product description, R&D brief, licensing & collaboration details, MoA & other evolving activities. It includes AP-102, atesidorsen sodium, COR-005, FP-002 , IONIS-GHRLRx ITF-2984, L-779976, octreotide acetate, octreotide acetate long acting, octreotide acetate SR, pasireotide ER, Neuroendocrine Tumors, Somadex, SXN-101959.
In the later part, the report provides an overview of key players involved in therapeutic development for Acromegaly and also features their dormant as well as discontinued projects. They are as follows: Aegis Therapeutics LLC, Chiasma Inc, Dauntless Pharmaceuticals Inc, Amryt Pharma plc, Strongbridge Biopharma plc, DexTech Medical AB, Antisense Therapeutics Ltd., Glide Pharmaceutical Technologies Ltd., Daewoong Pharmaceutical Co. Ltd., Midatech Pharma Plc, Silence Therapeutics Plc., Novartis AG and Others.
By the above major information, Acromegaly (Hormonal Disorders) pipeline guide helps buyers in identifying and tracking emerging players in the market and their portfolios enhance policymaking capabilities and help to create effective counter-strategies to gain competitive advantage.
Browse Full Report With TOC: http://www.marketresearchhub.com/report/acromegaly-pipeline-review-h1-2017-report.html
About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
Contact Us
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Follow us on:
Twitter: twitter.com/MktResearchHub
LinkedIn: www.linkedin.com/company/market-research-hub
Facebook: www.facebook.com/MarketResearchHub/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acromegaly Pipeline and Therapeutic Assessment, Drug Development by Companies Reviewed for H1 2017 here
News-ID: 539849 • Views: …
More Releases from Medical Industry Reports-[MRH]
Schistosomiasis Pipeline Insight: Pharmaceutical and Healthcare Report – 2017
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Schistosomiasis-Pipeline Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Schistosomiasis. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Schistosomiasis by development stage, therapy type, route of administration and molecule…
Global Atrial Fibrillation Drugs Sales Market Analysis Revealing Key Drivers & G …
The report on Atrial Fibrillation Drugs Sales Market is the latest addition to the huge database of Market Research Hub. This research study is segmented on the basis of applications, technology, geography, and types. The Report provides a detailed Atrial Fibrillation Drugs Sales Industry overview along with the analysis of industry’s gross margin, cost structure, consumption value, and sale price. The leading companies of the Atrial Fibrillation Drugs Sales Market,…
Global Urology Guidewires Sales Market Report 2017: Share, Size and Industry For …
The Market Research Hub’s report offers majority of the latest and newest industry data that covers the overall market situation along with future prospects for Urology Guidewires Sales Market around the globe. The research study includes significant data and also forecasts of the global market which makes the research report a helpful resource for marketing people, analysts, industry executives, consultants, sales and product managers, and other people who are in…
Global Breath Analyzers Sales Market Report 2017: Market Analysis Revealing Key …
A latest research report titled as ”Global Breath Analyzers Sales Market Report 2017” has been recently added to the vast portfolio of Market Research Hub (MRH) online research offerings. This report is a professional and in-depth analysis on the present state and future prospect for the global market. It provides valuable information to the industry insiders, potential entrants or investors. It includes an exhaustive enquiry with the reliability of logic…
More Releases for Acromegaly
Acromegaly - Drug Pipeline Landscape, 2022
Acromegaly is a rare hormonal condition that results from an excess amount of growth hormone (GH) in the body. The extra amount of GH causes excess growth in the bones and soft tissues of the body. Children with the condition can grow to abnormal heights.
The most common cause of acromegaly is a tumor in your pituitary gland called a pituitary adenoma that causes pituitary gland to release excess growth hormone…
Acromegaly Treatment Market Report Up to 2031
Visiongain has published a new report on Acromegaly Treatment Market Report to 2031: Forecasts By Disease Type (Ectopic Acromegaly and Pseudo Acromegaly), By Drug Class (Somatostatin Analogs (SSAs) (Somatuline Depot and Other SSAs), Dopamine Agonists (Bromocriptine Mesylate and Other Dopamine Agonists), and Growth Hormone Receptor Antagonist (Somavert)), By Route of Administration (Oral and Parenteral), and By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online pharmacies) PLUS COVID-19 Recovery Scenarios.
COVID-19 Impact…
Global Acromegaly Market Report Forecast to 2027
Acromegaly is a rare hormonal disease that occurs when the body produces too much growth hormone (GH). The excess GH promotes excessive development in the body's bones and soft tissues. The syndrome causes children to grow to very tall heights. They may also have a disproportionately large bone structure. Acromegaly is a condition that mostly affects the arms, legs, and face.
Get sample copy of this report @ …
Global Acromegaly Market Insights, Forecast
Acromegaly is a hormonal disorder that develops when your pituitary gland produces too much growth hormone during adulthood. When this happens, your bones increase in size, including those of your hands, feet and face. Acromegalyusually affects middle-aged adults. The global Acromegaly market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The…
Acromegaly Treatment Market Opportunity Analysis, 2018-2026
Acromegaly is a rare disorder caused due to the excess production of growth hormone by the pituitary gland, affecting a patient’s physical appearance and internal organs. It is usually caused by benign pituitary tumor (adenoma), however, in rare cases acromegaly symptoms can be observed due to ineffective control of growth hormone-secreting cells by hypothalamus. Abnormal enlargement of hands, arms, feet, legs, and head, and gradual changes in facial features such…
Global Acromegaly Treatment Market (Ectopic Acromegaly & Pseudo Acromegaly)Diagn …
Global acromegaly treatment market was valued at approximately USD +664.0 Million in 2016 and is expected to generate revenue of around USD +838.0 Million by the end of 2022, growing at a CAGR of around +3.94% between 2017 and 2022. There are various symptoms experienced by the patient like the protruded jaw, increased the size of limbs, the spacing between teeth of lower jaw and others. Conditions like hypertension, diabetes,…
